Last $9.76 USD
Change Today +0.23 / 2.41%
Volume 1.9M
MACK On Other Exchanges
Symbol
Exchange
NASDAQ GM
Frankfurt
As of 8:10 PM 11/26/14 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - merrimack pharmaceuticals in (MACK)

Name (Connections)Board RelationshipsTitleKey Developments
Sarah Nash 118 RelationshipsDirector and Chairman of Audit Committee 
Gordon Fehr 16 RelationshipsDirector, Chairman of Organization & Compensation Committee and Member of Audit Committee 
James Dresser 16 RelationshipsDirector and Member of Audit Committee 
James Quigley 284 RelationshipsDirector and Member of Audit Committee 

Compensation Committee* - merrimack pharmaceuticals in (MACK)

Name (Connections)Board RelationshipsTitle
Gordon Fehr 16 RelationshipsDirector, Chairman of Organization & Compensation Committee and Member of Audit Committee
John Mendelsohn M.D. 166 RelationshipsDirector and Member of Organization & Compensation Committee
Anthony Sinskey Sc.D. 98 RelationshipsCo-Founder, Director and Member of Organization & Compensation Committee
MACK Compensation vs. Industry
512.7K
363.9K
Chief Executive Officer
284.6K
267.5K
Chief Financial Officer
343.3K
348.2K
Chief Operating Officer
Share price activity for MERRIMACK PHARMACEUTICALS IN (MACK)
52 Week Price Performance
MACK
Industry Average

Nominating Committee* - merrimack pharmaceuticals in (MACK)

Name (Connections)Board RelationshipsTitleKey Developments
Gary Crocker 62 RelationshipsChairman, Chairman of Executive Committee and Member of Corporate Governance & Nominating CommitteeMerrimack Pharmaceuticals, Inc. Appoints James Quigley to Board of Directors
07/17/12
Michael Porter Ph.D. 68 RelationshipsStrategy Advisor, Director, Chairman of Corporate Governance & Nominating Committee and Member of Executive CommitteeMerrimack Pharmaceuticals, Inc. Announces Board Changes
07/13/12

Corporate Governance Committee* - merrimack pharmaceuticals in (MACK)

Name (Connections)Board RelationshipsTitle
Gary Crocker 62 RelationshipsDirector, Chairman of Organization & Compensation Committee and Member of Audit Committee
Michael Porter Ph.D. 68 RelationshipsDirector and Member of Organization & Compensation Committee
MACK and Competitor
Insiders vs. External
Board
18%
82%
Merrimack Pharmaceuticals, Inc.
Insiders
External Board Members

Executive Committee* - merrimack pharmaceuticals in (MACK)

Name (Connections)Board RelationshipsTitle
Gary Crocker 62 RelationshipsChairman, Chairman of Executive Committee and Member of Corporate Governance & Nominating Committee
Robert Mulroy 16 RelationshipsChief Executive Officer, President, Executive Director and Member of Executive Committee
Michael Porter Ph.D. 68 RelationshipsStrategy Advisor, Director, Chairman of Corporate Governance & Nominating Committee and Member of Executive Committee
Management Effectiveness Relative to the Industry
Return on Equity
41.8x
Return on Assets
NM
Return on Total Capital
NM
TEV/Total Revenue(LTM)
NM

Advisory Committee* - merrimack pharmaceuticals in (MACK)

Name (Board Relationships)/Title Board Affiliations
Christopher Benz 20 Relationships
Member of Scientific Advisory Board
No other board affiliations
Douglas Lauffenburger 85 Relationships
Member of Scientific Advisory Board
No other board affiliations
James Marks 55 Relationships
Member of Scientific Advisory Board
No other board affiliations
John Park 20 Relationships
Member of Scientific Advisory Board
No other board affiliations
Barret Rollins 29 Relationships
Member of Scientific Advisory Board
No other board affiliations
Peter Sorger 32 Relationships
Chairman of Scientific Advisory Board
No other board affiliations
Louis Weiner 64 Relationships
Member of Scientific Advisory Board
No other board affiliations
Michael Yaffe 58 Relationships
Member of Scientific Advisory Board
No other board affiliations
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MACK:US $9.76 USD +0.23

MACK Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MACK.
View Industry Companies
 

Industry Analysis

MACK

Industry Average

Valuation MACK Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MERRIMACK PHARMACEUTICALS IN, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.